Listed

IGC Pharma, Inc.: Form 10-K/A for the period ended Mar 31, 2013

Filed with the SEC on Jul 15, 2014 and accepted by EDGAR at Jul 14, 2014, 17:53 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2012-04-01 to 2013-03-31$8.0mus-gaap:Revenues
Cost of revenue12 months2012-04-01 to 2013-03-31$6.5mus-gaap:CostOfRevenue
Selling, general and administrative12 months2012-04-01 to 2013-03-31$3.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2012-04-01 to 2013-03-31−$2.5mus-gaap:OperatingIncomeLoss
Interest expense12 months2012-04-01 to 2013-03-31$419.4kus-gaap:InterestExpense
Income tax12 months2012-04-01 to 2013-03-31−$365.1kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2012-04-01 to 2013-03-31−$2.3mus-gaap:NetIncomeLoss
Diluted EPS12 months2012-04-01 to 2013-03-31−$0.32us-gaap:EarningsPerShareDiluted
Basic EPS12 months2012-04-01 to 2013-03-31−$0.32us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2012-04-01 to 2013-03-316,966,798 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2012-04-01 to 2013-03-31$564.8kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2012-04-01 to 2013-03-31$326.1kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-03-31$1.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-03-31$4.3mus-gaap:AssetsCurrent
Total assetsAt period end2013-03-31$19.3mus-gaap:Assets
Current liabilitiesAt period end2013-03-31$1.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-03-31$4.3mus-gaap:Liabilities
Short-term borrowingsAt period end2013-03-31$0us-gaap:ShortTermBorrowings
Shareholders' equityAt period end2013-03-31$14.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001185185-14-001791. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.